Standards of practice—medical cannabidiol, 13.15(1)
ARC 4248C
MEDICINE BOARD[653]
Adopted and Filed
Rule making related to standards of practice for medical cannabidiol
The Board of Medicine hereby amends Chapter 13, "Standards of Practice and Principles of Medical Ethics," Iowa Administrative Code.
Legal Authority for Rule Making
This rule making is adopted under the authority provided in Iowa Code chapters 124E, 148 and 272C.
State or Federal Law Implemented
This rule making implements, in whole or in part, Iowa Code chapter 124E.
Purpose and Summary
This rule making amends rule 653—13.15(124E,147,148,272C), which establishes the standards of practice for the use of medical cannabidiol, by adding "ulcerative colitis" to the list of debilitating medical conditions for which medical cannabidiol may be used.
Public Comment and Changes to Rule Making
Notice of Intended Action for this rule making was published in the Iowa Administrative Bulletin on October 24, 2018, as ARC 4082C. A public hearing was held on November 20, 2018, at 9 a.m. at the Board's office, Suite C, 400 S.W. Eighth Street, Des Moines, Iowa. No one attended the public hearing. No public comments were received. No changes from the Notice have been made.
Adoption of Rule Making
This rule making was adopted by the Board on December 14, 2018.
Fiscal Impact
This rule making has no fiscal impact to the State of Iowa.
Jobs Impact
After analysis and review of this rule making, no impact on jobs has been found.
Waivers
Any person who believes that the application of the discretionary provisions of this rule making would result in hardship or injustice to that person may petition the Board for a waiver of the discretionary provisions, if any, pursuant to 653—Chapter 3.
Review by Administrative Rules Review Committee
The Administrative Rules Review Committee, a bipartisan legislative committee which oversees rule making by executive branch agencies, may, on its own motion or on written request by any individual or group, review this rule making at its regular monthly meeting or at a special meeting. The Committee's meetings are open to the public, and interested persons may be heard as provided in Iowa Code section 17A.8(6).
Effective Date
This rule making will become effective on February 20, 2019.
The following rule-making action is adopted:
Amend subrule 13.15(1), definition of "Debilitating medical condition," as follows:
"Debilitating medical condition" means any of the following:
1.Cancer, if the underlying condition or treatment produces one or more of the following:
●Severe or chronic pain.
●Nausea or severe vomiting.
●Cachexia or severe wasting.
2.Multiple sclerosis with severe and persistent muscle spasms.
3.Seizures, including those characteristic of epilepsy.
4.AIDS or HIV as defined in Iowa Code section 141A.1.
5.Crohn's disease.
6.Amyotrophic lateral sclerosis.
7.Any terminal illness, with a probable life expectancy of under one year, if the illness or its treatment produces one or more of the following:
●Severe or chronic pain.
●Nausea or severe vomiting.
●Cachexia or severe wasting.
8.Parkinson's disease.
9.Untreatable pain.
10.Ulcerative colitis.
[Filed 12/19/18, effective 2/20/19]
[Published 1/16/19]
Editor's Note: For replacement pages for IAC, see IAC Supplement 1/16/19.
The official published PDF of this document is available from the Iowa General Assembly’s Administrative Rules page.
View the Iowa Administrative Bulletin for 1/16/2019.
The following administrative rule references were added to this document. You may click a reference to view related notices.
Rule 653-13.15(1)The following Iowa code references were added to this document. You may click a reference to view related notices.
Iowa Code 141A.1© 2024; State of Iowa | Privacy Policy